You just read:

NW Bio Announces Phase II Clinical Trial Program Combining DCVax®-L and Pembrolizumab (Keytruda®) for Colorectal Cancer

News provided by

Northwest Biotherapeutics

17 Nov, 2016, 08:15 ET